Vorhofflimmern

Aus PlusPedia
Wechseln zu: Navigation, Suche
Entstehender Artikel
Siehe auch
Freie Übersichtsartikel

[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68][69][70][71][72][73][74][75][76][77][78][79][80][81][82][83][84][85][86][87][88][89][90][91][92][93][94][95][96][97][98][99][100][101][102][103][104][105][106][107][108][109][110][111][112][113][114][115][116][117][118][119][120][121][122][123][124][125][126][127][128][129][130][131][132][133][134][135][136][137][138][139][140][141][142][143][144][145][146][147][148][149][150][151]

Wichtige Übersichtsartikel
Medline Suchterm/ Synonyme
Was ist das
Struktur
Physiologie
Knockout
Transgen
Mutation
Polymorphismus
Genexpression
Inhibitoren
Agonisten

1 Bibliographie

  1. Hochspringen ↑ Novel antithrombotic therapies for the prevention of stroke in patients with atrial fibrillation. Am J Manag Care 10(3 Suppl):S72-82 (2004) PMID 15152749
  2. Hochspringen ↑ Efficacy of anticoagulation for stroke prevention and risk stratification in atrial fibrillation: translating trials into clinical practice. Am J Manag Care 10(3 Suppl):S58-65 (2004) PMID 15152747
  3. Hochspringen ↑ Epidemiology and management of new-onset atrial fibrillation. Am J Manag Care 10(3 Suppl):S50-7 (2004) PMID 15152746
  4. Hochspringen ↑ Chessboard of atrial fibrillation: reentry or focus? Single or multiple source(s)? Neurogenic or myogenic? Am J Physiol Heart Circ Physiol 289(3):H977-9 (2005) PMID 16100254
  5. Hochspringen ↑ In the clinic. Atrial fibrillation. Ann Intern Med 149(9):ITC5-1-15; quiz ITC5-16 (2008) PMID 18981484
  6. Hochspringen ↑ Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146(12):857-67 (2007) PMID 17577005
  7. Hochspringen ↑ Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography. Ann Intern Med 139(12):1018-33 (2003) PMID 14678922
  8. Hochspringen ↑ Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med 139(12):1009-17 (2003) PMID 14678921
  9. Hochspringen ↑ Lessons from the Stroke Prevention in Atrial Fibrillation trials. Ann Intern Med 138(10):831-8 (2003) PMID 12755555
  10. Hochspringen ↑ Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention. Ann Intern Med 131(9):688-95 (1999) PMID 10577332
  11. Hochspringen ↑ Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 131(7):492-501 (1999) PMID 10507957
  12. Hochspringen ↑ Management of atrial fibrillation: simplicity surrounded by controversy. Ann Intern Med 126(3):244-6 (1997) PMID 9027278
  13. Hochspringen ↑ Atrial fibrillation: restoration and maintenance of sinus rhythm and indications for anticoagulation therapy. Ann Intern Med 125(4):311-23 (1996) PMID 8678396
  14. Hochspringen ↑ Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone. Ann Intern Med 120(6):449-57 (1994) PMID 8311367
  15. Hochspringen ↑ Surgical ablation of atrial fibrillation. Ann Thorac Cardiovasc Surg 11(5):285-7 (2005) PMID 16299453
  16. Hochspringen ↑ Surgery for atrial fibrillation. Ann Thorac Cardiovasc Surg 11(3):154-8 (2005) PMID 16030473
  17. Hochspringen ↑ When should heparin be given to patients with atrial fibrillation-related embolic brain infarcts? Arch Neurol 56(9):1059-60 (1999) PMID 10488804
  18. Hochspringen ↑ AUDIBLE ATRIAL FLUTTER: REPORT OF TWO CASES AND REVIEW OF THE LITERATURE. Cardiovasc Dis 2(3):320-324 (1975) PMID 15215918
  19. Hochspringen ↑ Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl):546S-592S (2008) PMID 18574273
  20. Hochspringen ↑ Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation: a useful complement to stroke risk stratification schema. Chest 130(5):1296-9 (2006) PMID 17099002
  21. Hochspringen ↑ The pathology of lone atrial fibrillation. Chest 127(2):424-5 (2005) PMID 15705975
  22. Hochspringen ↑ Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis. Chest 126(6):1938-45 (2004) PMID 15596696
  23. Hochspringen ↑ Medical cardioversion of atrial fibrillation. Chest 117(6):1529-31 (2000) PMID 10858374
  24. Hochspringen ↑ Transesophageal pacing in atrial flutter. Chest 92(1):4-5 (1987) PMID 3595247
  25. Hochspringen ↑ Evolving strategies in catheter ablation of long-standing atrial fibrillation. Circ Arrhythm Electrophysiol 1(5):324-6 (2008) PMID 19808426
  26. Hochspringen ↑ Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol 1(1):62-73 (2008) PMID 19808395
  27. Hochspringen ↑ The substrate maintaining persistent atrial fibrillation. Circ Arrhythm Electrophysiol 1(1):2-5 (2008) PMID 19808387
  28. Hochspringen ↑ Does bepridil create a paradigm shift in the treatment of persistent atrial fibrillation? Circ J 73(6):1008-9 (2009) PMID 19465779
  29. Hochspringen ↑ How useful is the 3-dimensional image for catheter ablation of atrial fibrillation? Circ J 73(3):436-7 (2009) PMID 19246822
  30. Hochspringen ↑ Treatment of paroxysmal atrial fibrillation by pulmonary vein isolation. Circ J 67(7):567-71 (2003) PMID 12845176
  31. Hochspringen ↑ Mounting evidence that fibrosis generates a major mechanism for atrial fibrillation. Circ Res 101(8):743-5 (2007) PMID 17932329
  32. Hochspringen ↑ Ionic remodeling in the heart: pathophysiological significance and new therapeutic opportunities for atrial fibrillation. Circ Res 87(6):440-7 (2000) PMID 10988234
  33. Hochspringen ↑ Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation 119(4):606-18 (2009) PMID 19188521
  34. Hochspringen ↑ Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Circulation 118(12):1285-93 (2008) PMID 18794401
  35. Hochspringen ↑ Atrial fibrillation-atrial flutter interactions: clinical implications for ablation. Circulation 116(24):2774-5 (2007) PMID 18071085
  36. Hochspringen ↑ Genes and atrial fibrillation: a new look at an old problem. Circulation 116(7):782-92 (2007) PMID 17698744
  37. Hochspringen ↑ ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114(7):e257-354 (2006) PMID 16908781
  38. Hochspringen ↑ Comparing different strategies for catheter ablation of atrial fibrillation. Circulation 111(22):2866-8 (2005) PMID 15939829
  39. Hochspringen ↑ ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Data Standards on Atrial Fibrillation). Circulation 109(25):3223-43 (2004) PMID 15226233
  40. Hochspringen ↑ ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation 104(17):2118-50 (2001) PMID 11673357
  41. Hochspringen ↑ Nonpharmacological approaches to atrial fibrillation. Circulation 103(16):2120-5 (2001) PMID 11319205
  42. Hochspringen ↑ Pathophysiology and prevention of atrial fibrillation. Circulation 103(5):769-77 (2001) PMID 11156892
  43. Hochspringen ↑ New approaches to the management of atrial fibrillation. The role of the atrial defibrillator. Circulation 98(16):1594-6 (1998) PMID 9778322
  44. Hochspringen ↑ Low-energy atrial defibrillation: a promising new technique. Circulation 98(9):833-4 (1998) PMID 9738635
  45. Hochspringen ↑ Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation 93(6):1262-77 (1996) PMID 8653857
  46. Hochspringen ↑ Atrial fibrillation subtypes, risk of stroke, and antithrombotic therapy. Eur Heart J 29(7):840-2 (2008) PMID 18334477
  47. Hochspringen ↑ Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? Eur Heart J 29(7):915-22 (2008) PMID 18334476
  48. Hochspringen ↑ Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey. Eur Heart J 29(5):632-9 (2008) PMID 18270212
  49. Hochspringen ↑ New oral anticoagulants in atrial fibrillation. Eur Heart J 29(2):155-65 (2008) PMID 18096568
  50. Hochspringen ↑ From MAZE to ICE: new concepts and new technologies for surgical ablation of atrial fibrillation. Eur Heart J 28(23):2827-9 (2007) PMID 17984135
  51. Hochspringen ↑ Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J 28(22):2803-17 (2007) PMID 17897924
  52. Hochspringen ↑ Management of atrial fibrillation in patients with heart failure. Eur Heart J 28(21):2568-77 (2007) PMID 17855740
  53. Hochspringen ↑ Stroke prevention in atrial fibrillation: antiplatelet therapy revisited. Eur Heart J 28(8):926-8 (2007) PMID 17430998
  54. Hochspringen ↑ Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis. Eur Heart J 28(4):457-62 (2007) PMID 17289748
  55. Hochspringen ↑ ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 27(16):1979-2030 (2006) PMID 16885201
  56. Hochspringen ↑ Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study). Eur Heart J 27(16):1954-64 (2006) PMID 16847008
  57. Hochspringen ↑ Anticoagulation for stroke prevention in atrial fibrillation: is gender important? Eur Heart J 27(16):1893-4 (2006) PMID 16820368
  58. Hochspringen ↑ Is atrial fibrillation an inflammatory disorder? Eur Heart J 27(2):136-49 (2006) PMID 16278230
  59. Hochspringen ↑ Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 26(20):2083-92 (2005) PMID 15975993
  60. Hochspringen ↑ Pulmonary vein stenosis: still the Achilles heel of ablation for atrial fibrillation? Eur Heart J 26(14):1355-7 (2005) PMID 15911568
  61. Hochspringen ↑ Towards more effective techniques for catheter ablation of atrial fibrillation: to aim for electrical disconnection of pulmonary veins or not? Eur Heart J 26(7):627-30 (2005) PMID 15637088
  62. Hochspringen ↑ Pharmacological cardioversion of recent onset atrial fibrillation. Eur Heart J 25(15):1274-6 (2004) PMID 15288151
  63. Hochspringen ↑ Quality of life in nonpharmacologic treatment of atrial fibrillation. Eur Heart J 24(15):1387-400 (2003) PMID 12909067
  64. Hochspringen ↑ Transoesophageal echocardiography for immediate and safe cardioversion in patients with atrial fibrillation. Eur Heart J 22(22):2041-4 (2001) PMID 11686658
  65. Hochspringen ↑ ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 22(20):1852-923 (2001) PMID 11601835
  66. Hochspringen ↑ Randomized trial of rhythm or rate control in atrial fibrillation: the Pharmacological Intervention in Atrial Fibrillation Trial (PIAF). Eur Heart J 22(10):801-2 (2001) PMID 11350085
  67. Hochspringen ↑ The optimal management of cardioversion of atrial fibrillation or flutter: still a 'stunning' problem. Eur Heart J 21(10):795-8 (2000) PMID 10781349
  68. Hochspringen ↑ Systematic review of the management of atrial fibrillation in patients with heart failure. Eur Heart J 21(8):614-32 (2000) PMID 10731399
  69. Hochspringen ↑ Cardioversion of chronic atrial fibrillation-towards a more aggressive approach. Eur Heart J 21(4):263 (2000) PMID 10653670
  70. Hochspringen ↑ Chronic atrial fibrillation-how to best reach a permanent sinus rhythm? Eur Heart J 21(1):11-2 (2000) PMID 10610736
  71. Hochspringen ↑ Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J 19(9):1294-320 (1998) PMID 9792255
  72. Hochspringen ↑ Anticoagulation for cardioversion of atrial arrhythmias. Eur Heart J 19(4):548-52 (1998) PMID 9597402
  73. Hochspringen ↑ Intravenous digoxin: still the drug of choice for acute termination of atrial fibrillation? Eur Heart J 18(4):546-7 (1997) PMID 9129879
  74. Hochspringen ↑ Unravelling the electrical mysteries of atrial fibrillation. Eur Heart J 17 Suppl C():2-9 (1996) PMID 8809533
  75. Hochspringen ↑ Identification, diagnosis and assessment of atrial fibrillation. Heart 93(1):25-8 (2007) PMID 16952973
  76. Hochspringen ↑ Rate control in the medical management of atrial fibrillation. Heart 93(1):35-8 (2007) PMID 16952972
  77. Hochspringen ↑ Antithrombotic treatment in atrial fibrillation. Heart 93(1):39-44 (2007) PMID 16952971
  78. Hochspringen ↑ Acute management of atrial fibrillation with acute haemodynamic instability and in the postoperative setting. Heart 93(1):45-7 (2007) PMID 16952970
  79. Hochspringen ↑ Patient care pathway, implementation and audit criteria for patients with atrial fibrillation. Heart 93(1):48-52 (2007) PMID 16952969
  80. Hochspringen ↑ The new NICE guideline on atrial fibrillation management. Heart 93(1):23 (2007) PMID 16952968
  81. Hochspringen ↑ Rhythm control strategies for "symptomatic" persistent atrial fibrillation: is achieving sinus rhythm enough? Heart 92(9):1189-90 (2006) PMID 16644853
  82. Hochspringen ↑ Management of atrial fibrillation. Heart 92(8):1177-82 (2006) PMID 16844883
  83. Hochspringen ↑ Catheter and surgical ablation of atrial fibrillation. Heart 92(2):266-74 (2006) PMID 16415203
  84. Hochspringen ↑ Can we ablate permanent atrial fibrillation? Heart 92(2):152-4 (2006) PMID 16308414
  85. Hochspringen ↑ Antithrombotic treatment in atrial fibrillation. Heart 92(2):155-61 (2006) PMID 16159980
  86. Hochspringen ↑ Atrial fibrillation ablation in the real world. Heart 91(12):1507-8 (2005) PMID 16287725
  87. Hochspringen ↑ Catheter ablation for atrial fibrillation. Heart 91(1):7-9 (2005) PMID 15604320
  88. Hochspringen ↑ Theory and practice of defibrillation: (1) Atrial fibrillation and DC conversion. Heart 90(12):1493-8 (2004) PMID 15547045
  89. Hochspringen ↑ Importance of using biphasic shock waveforms for cardioversion from atrial fibrillation: an unresolved issue. Heart 90(10):1105-6 (2004) PMID 15367497
  90. Hochspringen ↑ Role of oral anticoagulation in management of atrial fibrillation. Heart 90(7):813-7 (2004) PMID 15201261
  91. Hochspringen ↑ The role of echocardiography in atrial fibrillation and cardioversion. Heart 89(12):1447-54 (2003) PMID 14617563
  92. Hochspringen ↑ Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment. Heart 89(8):939-43 (2003) PMID 12860883
  93. Hochspringen ↑ Pacing for atrial fibrillation. Heart 89(1):106-12 (2003) PMID 12482808
  94. Hochspringen ↑ Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation. Heart 87(6):535-43 (2002) PMID 12010934
  95. Hochspringen ↑ Current perspectives on curative catheter ablation of atrial fibrillation. Heart 87(1):6-8 (2002) PMID 11751651
  96. Hochspringen ↑ Atrial fibrillation: towards an understanding of initiation, perpetuation, and specific treatment. Heart 80(6):533-4 (1998) PMID 10065016
  97. Hochspringen ↑ Ablate and pace: a pragmatic approach to paroxysmal atrial fibrillation not controlled by antiarrhythmic drugs. Heart 79(6):531-3 (1998) PMID 10078073
  98. Hochspringen ↑ Heart failure and atrial fibrillation: current concepts and controversies. Heart 77(4):309-13 (1997) PMID 9155607
  99. Hochspringen ↑ Problems in the pharmacological evaluation of paroxysmal atrial fibrillation. Intern Med 37(12):997-8 (1998) PMID 9932625
  100. Hochspringen ↑ Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 290(20):2685-92 (2003) PMID 14645310
  101. Hochspringen ↑ Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285(22):2864-70 (2001) PMID 11401607
  102. Hochspringen ↑ Preventing stroke in patients with atrial fibrillation. JAMA 281(19):1830-5 (1999) PMID 10340371
  103. Hochspringen ↑ Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies. Mayo Clin Proc 84(7):643-62 (2009) PMID 19567719
  104. Hochspringen ↑ The increasing need for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Mayo Clin Proc 79(7):904-13 (2004) PMID 15244388
  105. Hochspringen ↑ Direct current cardioversion of atrial fibrillation--the next 40 years. Mayo Clin Proc 77(9):895-6 (2002) PMID 12233920
  106. Hochspringen ↑ Atrial fibrillation in dialysis patients. Nephrol Dial Transplant 15(6):765-8 (2000) PMID 10831625
  107. Hochspringen ↑ Emergency management of atrial fibrillation. Postgrad Med J 79(932):313-9 (2003) PMID 12840118
  108. Hochspringen ↑ Present treatment options for atrial fibrillation. Postgrad Med J 79(928):67-73 (2003) PMID 12612318
  109. Hochspringen ↑ Cardioversion of atrial fibrillation. Postgrad Med J 71(838):457-65 (1995) PMID 7567751
  110. Hochspringen ↑ Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke 40(1):235-40 (2009) PMID 18757287
  111. Hochspringen ↑ Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians. Stroke 39(1):227-30 (2008) PMID 18048861
  112. Hochspringen ↑ Predicting stroke risk in patients with atrial fibrillation. Stroke 38(9):2409 (2007) PMID 17673800
  113. Hochspringen ↑ Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation. Stroke 38(2 Suppl):624-30 (2007) PMID 17261703
  114. Hochspringen ↑ Advances in surgical treatment of atrial fibrillation. Stroke 38(2 Suppl):618-23 (2007) PMID 17261702
  115. Hochspringen ↑ Stroke prevention in atrial fibrillation: pharmacological rate versus rhythm control. Stroke 38(2 Suppl):615-7 (2007) PMID 17261701
  116. Hochspringen ↑ Atrial fibrillation and stroke : concepts and controversies. Stroke 32(3):803-8 (2001) PMID 11239205
  117. Hochspringen ↑ Underuse of antithrombotic therapy in stroke patients with chronic atrial fibrillation. Stroke 31(9):2266-7 (2000) PMID 10978142
  118. Hochspringen ↑ Warfarin use among patients with atrial fibrillation. Stroke 28(12):2382-9 (1997) PMID 9412618
  119. Hochspringen ↑ Atrial fibrillation and stroke. Mortality and causes of death after the first acute ischemic stroke. Stroke 28(2):311-5 (1997) PMID 9040681
  120. Hochspringen ↑ Thromboembolic complications in atrial fibrillation. Stroke 21(1):4-13 (1990) PMID 2405547
  121. Hochspringen ↑ Atrial fibrillation and stroke: new ideas, persisting dilemmas. Stroke 19(8):937-41 (1988) PMID 3041652
  122. Hochspringen ↑ Mapping of atrial fibrillation--basic research and clinical applications. Swiss Med Wkly 139(35-36):496-504 (2009) PMID 19736589
  123. Hochspringen ↑ Atrial fibrillation: estimated excess rate of stroke due to lacking adherence to guidelines. Swiss Med Wkly 136(47-48):757-60 (2006) PMID 17225195
  124. Hochspringen ↑ Atrial fibrillation: the most common arrhythmia. Tex Heart Inst J 27(3):257-67 (2000) PMID 11093410
  125. Hochspringen ↑ Low-energy internal cardioversion of atrial fibrillation after failed external cardioversion: Texas Heart Institute experience and review of the literature. Tex Heart Inst J 26(2):114-9 (1999) PMID 10397433
  126. Hochspringen ↑ Anticoagulation and atrial fibrillation. Putting the results of clinical trials into practice. West J Med 163(2):145-52 (1995) PMID 7571562
  127. Hochspringen ↑ Treatment of nonvalvular atrial fibrillation. West J Med 162(4):331-9 (1995) PMID 7747499
  128. Hochspringen ↑ Common causes of cardiac emboli--left ventricular thrombi and atrial fibrillation. West J Med 151(2):172-9 (1989) PMID 2672600
  129. Hochspringen ↑ Familial congenital brachial palsy. Am J Med Genet 41(3):322-4 (1991) PMID 1789287
  130. Hochspringen ↑ Mystery of biphasic defibrillation waveform efficacy is it calcium? J Am Coll Cardiol 52(10):836-8 (2008) PMID 18755346
  131. Hochspringen ↑ Molecular genetics of atrial fibrillation. J Am Coll Cardiol 52(4):241-50 (2008) PMID 18634977
  132. Hochspringen ↑ Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. J Am Coll Cardiol 51(8):828-35 (2008) PMID 18294568
  133. Hochspringen ↑ Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 51(8):802-9 (2008) PMID 18294563
  134. Hochspringen ↑ Atrial-selective approaches for the treatment of atrial fibrillation. J Am Coll Cardiol 51(8):787-92 (2008) PMID 18294561
  135. Hochspringen ↑ Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol 51(1):1-11 (2008) PMID 18174029
  136. Hochspringen ↑ Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol 50(21):2021-8 (2007) PMID 18021867
  137. Hochspringen ↑ Is pulmonary vein antrum isolation a critical determinant of recurrent arrhythmias after ablation of atrial fibrillation? J Am Coll Cardiol 50(9):875-6 (2007) PMID 17719474
  138. Hochspringen ↑ Cardiovascular imaging in the management of atrial fibrillation. J Am Coll Cardiol 48(10):2077-84 (2006) PMID 17112997
  139. Hochspringen ↑ ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 48(4):854-906 (2006) PMID 16904574
  140. Hochspringen ↑ Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 45(11):1832-9 (2005) PMID 15936615
  141. Hochspringen ↑ Drug-induced atrial fibrillation. J Am Coll Cardiol 44(11):2117-24 (2004) PMID 15582307
  142. Hochspringen ↑ ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Commitee to Develop Data Standards on Atrial Fibrillation). J Am Coll Cardiol 44(2):475-95 (2004) PMID 15261958
  143. Hochspringen ↑ Obliteration of the left atrial appendage for prevention of thromboembolism. J Am Coll Cardiol 42(7):1259-61 (2003) PMID 14522492
  144. Hochspringen ↑ Restoring sinus rhythm in atrial fibrillation: a Pyrrhic victory? J Am Coll Cardiol 42(1):30-2 (2003) PMID 12849655
  145. Hochspringen ↑ Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis. J Am Coll Cardiol 41(2):255-62 (2003) PMID 12535819
  146. Hochspringen ↑ High intensity anticoagulation for cardioversion of atrial arrhythmias? The shocking truth. J Am Coll Cardiol 40(5):934-6 (2002) PMID 12225718
  147. Hochspringen ↑ Initial energy setting, outcome and efficiency in direct current cardioversion of atrial fibrillation and flutter. J Am Coll Cardiol 38(5):1498-504 (2001) PMID 11691530
  148. Hochspringen ↑ ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 38(4):1231-66 (2001) PMID 11583910
  149. Hochspringen ↑ Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation. J Am Coll Cardiol 37(3):691-704 (2001) PMID 11693739
  150. Hochspringen ↑ Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 37(2):371-8 (2001) PMID 11216949
  151. Hochspringen ↑ Identification of variables needed to risk adjust outcomes of coronary interventions: evidence-based guidelines for efficient data collection. J Am Coll Cardiol 32(1):275-82 (1998) PMID 9669281

2 Andere Lexika

Abgerufen von „http://de.pluspedia.org/w/index.php?title=Vorhofflimmern&oldid=42529“

Diesen Artikel melden!
Verletzt dieser Artikel deine Urheber- oder Persönlichkeitsrechte?
Hast du einen Löschwunsch oder ein anderes Anliegen? Dann nutze bitte unser Kontaktformular

PlusPedia Impressum
Diese Seite mit Freunden teilen:
Mr Wong Digg Delicious Yiggit wikio Twitter
Facebook


Bitte Beachte:
Sämtliche Aussagen auf dieser Seite sind ohne Gewähr.
Für die Richtigkeit der Aussagen übernimmt die Betreiberin keine Verantwortung.
Nach Kenntnissnahme von Fehlern und Rechtsverstößens ist die Betreiberin selbstverständlich bereit,
diese zu beheben.

Verantwortlich für jede einzelne Aussage ist der jeweilige Erstautor dieser Aussage.
Mit dem Ergänzen und Weiterschreiben eines Artikels durch einen anderen Autor
werden die vorhergehenden Aussagen und Inhalte nicht zu eigenen.
Die Weiternutzung und Glaubhaftigkeit der Inhalte ist selbst gegenzurecherchieren.


Typo3 Besucherzähler - Seitwert blog counter
java hosting vpn norway